Biofrank Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 3.37%
(FY 2023)
- Profit -1512.33%
(FY 2023)
- Ebitda -1013.45%
(FY 2023)
- Net Worth -995.10%
(FY 2023)
- Total Assets 28.04%
(FY 2023)
About Biofrank Pharmaceuticals (India)
The Corporate was formerly known as Biofrank Pharmaceuticals Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Munish Manchanda and Meenakshi serve as directors at the Company.
- CIN/LLPIN
U24304HR2018PTC076427
- Company No.
076427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biofrank Pharmaceuticals (India) Private Limited offer?
Biofrank Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Hand Sanitizers & Personal Hygiene, Face Wash, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Fitness Supplements, Flavours & Aromatics.
Who are the key members and board of directors at Biofrank Pharmaceuticals (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Manchanda  | Director | 15-Oct-2018 | Current |
| Meenakshi | Director | 18-May-2024 | Current |
Financial Performance of Biofrank Pharmaceuticals (India).
Biofrank Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial fall in profitability, with a 1512.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 995.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biofrank Pharmaceuticals (India)?
In 2023, Biofrank Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prosem Healthcare Private LimitedActive 4 years 1 monthMunish Manchanda and Meenakshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biofrank Pharmaceuticals (India)?
Unlock and access historical data on people associated with Biofrank Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofrank Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofrank Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
